Outcome | Control group | Â | Intervention group | Â | Â |
---|---|---|---|---|---|
 | % exceeding MCID |  | % exceeding MCID | ANCOVA | |
VISA-A | |||||
 Baseline | 68.2 (17.2) |  | 64.2 (13.6) |  |  |
 Week 6 | 75.8 (13.0) |  | 82.3 (10.3) |  |  |
 Week 12 | 84.7 (11.5) |  | 86.4 (18.2) |  |  |
 Mean difference at 6 weeks (95% CI) | 7.6 (0.28 to 14.9) | 33 | 18.1 (10.2 to 26.0) | 75 | p = 0.037 η2 = 0.192 |
 Mean difference at 12 weeks (95% CI) | 16.5 (8.5 to 24.5) | 58 | 22.3 (12.5 to 32.0) | 75 | p = 0.447 η2 = 0.028 |
Left heel-raises (n) | |||||
 Baseline | 20.8 (8.7) |  | 25.9 (11.9) |  |  |
 Week 6 | 25.0 (8.8) |  | 30.2 (15.5) |  |  |
 Week 12 | 28.8 (11.6) |  | 38.2 (18.1) |  |  |
 Mean difference at 6 weeks (95% CI) | 4.2 (0.6 to 7.7) |  | 4.3 (− 1.0 to 9.5) |  |  |
 Mean difference at 12 weeks (95% CI) | 7.9 (2.9 to 12.9) |  | 12.2 (3.4 to 21) |  |  |
Right heel-raises (n) | |||||
 Baseline | 22.6 (8.2) |  | 25.3 (10.6) |  |  |
 Week 6 | 24.8 (9.5) |  | 28.7 (10.9) |  |  |
 Week 12 | 28.7 (10.6) |  | 33.9 (14.6) |  |  |
 Mean difference at 6 weeks (95% CI) | 2.2 (− 1.6 to 6.0) |  | 3.42 (− 0.9 to 7.7) |  |  |
 Mean difference at 12 weeks (95% CI) | 6.1 (0.5 to 11.6) |  | 8.6 (3 to 14.4) |  |  |
Left Hop Test (NPRS) | |||||
 Baseline | 4.8 (2) |  | 4.1 (1.9) |  |  |
 Week 6 | 2.29 (2.43) |  | 2.7 (2.2) |  |  |
 Week 12 | 1.14 (1.86) |  | 0.8 (1.6) |  |  |
 Mean difference at 6 weeks (95% CI) | − 2.6 (− 4.5 to − 0.7) |  | − 1.1 (− 3.4 to 1.2) |  |  |
 Mean difference at 12 weeks (95% CI) | − 3.4 (− 5.9 to − 1.0) |  | − 3.3 (− 5.9 to − 0.8) |  |  |
Right hop test (NPRS) | |||||
 Baseline | 3.3 (1.5) |  | 5.1 (1.7) |  |  |
 Week 6 | 1.6 (2.3) |  | 1.7 (3.6) |  |  |
 Week 12 | 0.5 (1.0) |  | 1.7 (2.9) |  |  |
 Mean difference at 6 weeks (95% CI) | − 0.8 (− 1.8 to .24) |  | − 3.3 (− 6.5 to − 0.2) |  |  |
 Mean difference at 12 weeks (95% CI) | − 2.3 (− 5.5 – 1.0) |  | − 3.8 (− 6.7 to − 1.0) |  |  |
NPRS | |||||
 Baseline | 5.6 (1.9) |  | 5.3 (2.3) |  |  |
 Week 6 | 4.4 (2.1) |  | 3.3 (2.4) |  |  |
 Week 12 | 1.8 (1.29) |  | 1.3 (2.1) |  |  |
 Mean difference at 6 weeks (95% CI) | − 1.2 (− 2.4 to 0.1) | 58 | − 1.9 (− 3.7 to − 0.2) | 50 |  |
 Mean difference at 12 weeks (95% CI) | − 3.8 (− 5.2 to − 2.5) | 75 | − 4 (− 5.7 to − 2.3) | 83 |  |
LEFS | |||||
 Baseline | 78.9 (15.2) |  | 77.0 (16.6) |  |  |
 Week 6 | 84.5 (12.2) |  | 88.7 (9.6) |  |  |
 Week 12 | 94.5 (7.41) |  | 92.9 (8.5) |  |  |
 Mean difference at 6 weeks (95% CI) | 5.6 (1.5 to 9.8) | 17 | 11.7 (4.1 to 19.3) | 42 |  |
 Mean difference at 12 weeks (95% CI) | 15.6 (8.7 to 22.6) | 66 | 16 (8.3 to 23.6) | 58 |  |
PSEQ | |||||
 Baseline | 52.8 (7.4) |  | 52.75 (7.0) |  |  |
 Week 6 | 55.6 (6.1) |  | 54.7 (4.7) |  |  |
 Week 12 | 57.3 (4.3) |  | 56.7 (4.6) |  |  |
 Mean difference at 6 weeks (95% CI) | 2.8 (0.1 to 5.6) | 0 | 2.8 (− 1.1 to 6.6) | 25 |  |
 Mean difference at 12 weeks (95% CI) | 4.6 (1.3 to 7.9) | 17 | 4.8 (1.5 to 8.0) | 8 |  |
EUROQOL-5D VAS | |||||
 Baseline (95% CI) | 83.9 (78.9 to 88.8) |  | 80.0 (72.3 to 85.7) |  |  |
 Week 6 (95% 5CI) | 85.0 (80.1 to 89.9) |  | 82.5 (73.9 to 91.1) |  |  |
 WEEK 12 (95%CI) | 87.0 (82.7 to 91.5) |  | 82.4 (74.2 to 90.6) |  |  |
PGIC | Â | Â | Â | Â | Â |
 Very much improved week 6/week 12(N) | 1/6 |  | 4/8 |  |  |
 Much improved week 6/week 12 (N) | 6/5 |  | 4/1 |  |  |
 Minimally improved week 6 /week 12 (N) | 5/1 |  | 2/2 |  |  |
 No change week 6/week 12 (N) | 0/0 |  | 1/0 |  |  |
 Minimally worse week 6/week 12 (N) | 0/0 |  | 1/1 |  |  |
Satisfaction Q | |||||
 Excellent week 6/week 12 (N) | 5/7 |  | 8/9 |  |  |
 Good week 6/week 12 (N) | 4/3 |  | 1/1 |  |  |
 Moderate week 6/week 12 (N) | 3/2 |  | 3/1 |  |  |
 POOR week 6/week 12 (N) | 0/0 |  | 0/1 |  |  |
IPAQ | |||||
 Week 6 high/moderate/low | 6/6/0 |  | 3/8/1 |  |  |
 week 12 high/moderate/low | 8/3/1 |  | 3/8/1 |  |  |
 |  | N exceeding threshold |  | N exceeding threshold |
---|---|---|---|---|
PCS | ||||
 Baseline | 14.7 (14.0) | 3 | 15.6 (8.3) | 1 |
 Week 6 | 8.4 (9.1) | 1 | 6.6 (3.8) | 0 |
 Week 12 | 2.9 (2.2) | 0 | 3.7 (2.8) | 0 |
 Mean difference at 6 weeks (95% CI) | − 6.3 (− 12.1 to − 0.4) |  | − 9.0 (− 14.4 to − 3.7) |  |
 Mean difference at 12 weeks (95% CI) | − 11.8 (− 20.9 to − 2.6) |  | − 11.9 (− 17.8 to − 6.0) |  |
TSK | ||||
 Baseline | 34.6 (7.6) |  | 38.4 (6.1) |  |
 Week 6 | 33.3 (4.5) | 2 | 34.0 (6.3) | 4 |
Week 12 | 28.5 (5.2) | 1 | 30.8 (6.2) | 3 |
 Mean difference at 6 weeks (95% CI) | − 1.3 (− 4.4 to 1.9) |  | − 4.4 (− 6.2 to − 2.7) |  |
 Mean difference at 12 weeks (95% CI) | − 6.1 (− 9.9 to − 2.3) |  | − 7.67 (− 11.3 to − 4.0) |  |